120 related articles for article (PubMed ID: 28653752)
1. The potential of Epimedium koreanum Nakai for herb-drug interaction.
Zhong Q; Shi Z; Zhang L; Zhong R; Xia Z; Wang J; Wu H; Jiang Y; Sun E; Wei Y; Feng L; Zhang Z; Liu D; Song J; Jia X
J Pharm Pharmacol; 2017 Oct; 69(10):1398-1408. PubMed ID: 28653752
[TBL] [Abstract][Full Text] [Related]
2. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay.
Pandit S; Kanjilal S; Awasthi A; Chaudhary A; Banerjee D; Bhatt BN; Narwaria A; Singh R; Dutta K; Jaggi M; Singh AT; Sharma N; Katiyar CK
J Ethnopharmacol; 2017 Feb; 197():165-172. PubMed ID: 27457692
[TBL] [Abstract][Full Text] [Related]
5. The potential of Hypoxis hemerocallidea for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; Bouic PJ; Rosenkranz B
Pharm Biol; 2013 Dec; 51(12):1499-507. PubMed ID: 23844611
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
Doehmer J; Weiss G; McGregor GP; Appel K
Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
9. In vitro assessment of CYP1A2 and 2C9 inhibition potential of Withania somnifera and Centella asiatica in human liver microsomes.
Savai J; Varghese A; Pandita N; Chintamaneni M
Drug Metab Pers Ther; 2015 Jun; 30(2):137-41. PubMed ID: 25938222
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
[TBL] [Abstract][Full Text] [Related]
12. Metabolism-mediated interaction potential of standardized extract of
Bahadur S; Mukherjee PK; Milan Ahmmed SK; Kar A; Harwansh RK; Pandit S
Indian J Pharmacol; 2016; 48(5):576-581. PubMed ID: 27721546
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro inhibition and induction of cytochrome P450 activities by hydrolyzed ginkgolides.
Zhou XW; Ma Z; Geng T; Wang ZZ; Ding G; Yu-an B; Xiao W
J Ethnopharmacol; 2014 Dec; 158 Pt A():132-9. PubMed ID: 25456428
[TBL] [Abstract][Full Text] [Related]
15. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
[TBL] [Abstract][Full Text] [Related]
17. Significant inhibitory impact of dibenzyl trisulfide and extracts of Petiveria alliacea on the activities of major drug-metabolizing enzymes in vitro: An assessment of the potential for medicinal plant-drug interactions.
Murray J; Picking D; Lamm A; McKenzie J; Hartley S; Watson C; Williams L; Lowe H; Delgoda R
Fitoterapia; 2016 Jun; 111():138-46. PubMed ID: 27105957
[TBL] [Abstract][Full Text] [Related]
18. In vitro Inhibitory Effects of Isofraxidin on Human Liver Cytochrome P450 Enzymes.
Song X; Dong G; Zhou Y
Pharmacology; 2019; 103(3-4):120-127. PubMed ID: 30544127
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
[TBL] [Abstract][Full Text] [Related]
20. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
